APO Research

APO RESEARCH · REPORT

Cholesterol-Lowering Supplements

Selected research

Market Structure

Global Cholesterol-Lowering Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Cholesterol-Lowering Supplements market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cholesterol-Lowering Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cholesterol-Lowering Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cholesterol-Lowering Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cholesterol-Lowering Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cholesterol-Lowering Supplements include Vitabiotics, TCI Co. Ltd., Streamline Pharma Pvt. Ltd., Step One Foods, Solgar, Pure Encapsulations LLC, ORGANIC INDIA Pvt. Ltd., Inlife Pharma Private Limite and Holland & Barrett, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cholesterol-Lowering Supplements market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cholesterol-Lowering Supplements and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cholesterol-Lowering Supplements sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cholesterol-Lowering Supplements market size, projected growth trends, production technologies, key applications, and end-use industries.

Cholesterol-Lowering Supplements Segment by Company

Vitabiotics

TCI Co. Ltd.

Streamline Pharma Pvt. Ltd.

Step One Foods

Solgar

Pure Encapsulations LLC

ORGANIC INDIA Pvt. Ltd.

Inlife Pharma Private Limite

Holland & Barrett

Himalaya Wellness Company.

HERBAL CREATIONS

Croda International Plc

Cargill

Bioglan

ADM

Cholesterol-Lowering Supplements Segment by Type

Animal-Based

Plant-Based

Others

Cholesterol-Lowering Supplements Segment by Application

Online Sales

Offline Sales

Cholesterol-Lowering Supplements Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cholesterol-Lowering Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cholesterol-Lowering Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cholesterol-Lowering Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cholesterol-Lowering Supplements market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cholesterol-Lowering Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cholesterol-Lowering Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cholesterol-Lowering Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cholesterol-Lowering Supplements Industry Trends Table 2. Cholesterol-Lowering Supplements Industry Drivers Table 3. Cholesterol-Lowering Supplements Industry Opportunities and Challenges Table 4. Cholesterol-Lowering Supplements Industry Restraints Table 5. Global Cholesterol-Lowering Supplements Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cholesterol-Lowering Supplements Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cholesterol-Lowering Supplements Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Cholesterol-Lowering Supplements Sales Market Share by Manufacturers Table 9. Global Cholesterol-Lowering Supplements Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Cholesterol-Lowering Supplements Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cholesterol-Lowering Supplements Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cholesterol-Lowering Supplements Manufacturers, Product Type & Application Table 13. Global Cholesterol-Lowering Supplements Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cholesterol-Lowering Supplements by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Animal-Based Table 17. Major Manufacturers of Plant-Based Table 18. Major Manufacturers of Others Table 19. Global Cholesterol-Lowering Supplements Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Cholesterol-Lowering Supplements Sales by Type (2021-2026) & (Tons) Table 21. Global Cholesterol-Lowering Supplements Sales by Type (2027-2032) & (Tons) Table 22. Global Cholesterol-Lowering Supplements Sales Market Share by Type (2021-2026) Table 23. Global Cholesterol-Lowering Supplements Sales Market Share by Type (2027-2032) Table 24. Global Cholesterol-Lowering Supplements Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 25. Global Cholesterol-Lowering Supplements Revenue by Type (2021-2026) & (Tons) Table 26. Global Cholesterol-Lowering Supplements Revenue by Type (2027-2032) & (Tons) Table 27. Global Cholesterol-Lowering Supplements Revenue Market Share by Type (2021-2026) Table 28. Global Cholesterol-Lowering Supplements Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Online Sales Table 30. Major Manufacturers of Offline Sales Table 31. Global Cholesterol-Lowering Supplements Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 32. Global Cholesterol-Lowering Supplements Sales by Application (2021-2026) & (Tons) Table 33. Global Cholesterol-Lowering Supplements Sales by Application (2027-2032) & (Tons) Table 34. Global Cholesterol-Lowering Supplements Sales Market Share by Application (2021-2026) Table 35. Global Cholesterol-Lowering Supplements Sales Market Share by Application (2027-2032) Table 36. Global Cholesterol-Lowering Supplements Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 37. Global Cholesterol-Lowering Supplements Revenue by Application (2021-2026) & (Tons) Table 38. Global Cholesterol-Lowering Supplements Revenue by Application (2027-2032) & (Tons) Table 39. Global Cholesterol-Lowering Supplements Revenue Market Share by Application (2021-2026) Table 40. Global Cholesterol-Lowering Supplements Revenue Market Share by Application (2027-2032) Table 41. Global Cholesterol-Lowering Supplements Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 42. Global Cholesterol-Lowering Supplements Sales by Region (2021-2026) & (Tons) Table 43. Global Cholesterol-Lowering Supplements Sales Market Share by Region (2021-2026) Table 44. Global Cholesterol-Lowering Supplements Sales Forecasted by Region (2027-2032) & (Tons) Table 45. Global Cholesterol-Lowering Supplements Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Cholesterol-Lowering Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 47. North America Cholesterol-Lowering Supplements Sales by Country (2021-2026) & (Tons) Table 48. North America Cholesterol-Lowering Supplements Sales by Country (2027-2032) & (Tons) Table 49. Europe Cholesterol-Lowering Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 50. Europe Cholesterol-Lowering Supplements Sales by Country (2021-2026) & (Tons) Table 51. Europe Cholesterol-Lowering Supplements Sales by Country (2027-2032) & (Tons) Table 52. Asia Pacific Cholesterol-Lowering Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 53. Asia Pacific Cholesterol-Lowering Supplements Sales by Country (2021-2026) & (Tons) Table 54. Asia Pacific Cholesterol-Lowering Supplements Sales by Country (2027-2032) & (Tons) Table 55. South America, Middle East and Africa Cholesterol-Lowering Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. South America, Middle East and Africa Cholesterol-Lowering Supplements Sales by Country (2021-2026) & (Tons) Table 57. South America, Middle East and Africa Cholesterol-Lowering Supplements Sales by Country (2027-2032) & (Tons) Table 58. Global Cholesterol-Lowering Supplements Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Cholesterol-Lowering Supplements Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Cholesterol-Lowering Supplements Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Cholesterol-Lowering Supplements Revenue Market Share by Region (2021-2026) Table 62. Global Cholesterol-Lowering Supplements Revenue Market Share by Region (2027-2032) Table 63. Vitabiotics Company Information Table 64. Vitabiotics Business Overview Table 65. Vitabiotics Cholesterol-Lowering Supplements Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Vitabiotics Cholesterol-Lowering Supplements Product Portfolio Table 67. Vitabiotics Recent Development Table 68. TCI Co. Ltd. Company Information Table 69. TCI Co. Ltd. Business Overview Table 70. TCI Co. Ltd. Cholesterol-Lowering Supplements Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. TCI Co. Ltd. Cholesterol-Lowering Supplements Product Portfolio Table 72. TCI Co. Ltd. Recent Development Table 73. Streamline Pharma Pvt. Ltd. Company Information Table 74. Streamline Pharma Pvt. Ltd. Business Overview Table 75. Streamline Pharma Pvt. Ltd. Cholesterol-Lowering Supplements Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Streamline Pharma Pvt. Ltd. Cholesterol-Lowering Supplements Product Portfolio Table 77. Streamline Pharma Pvt. Ltd. Recent Development Table 78. Step One Foods Company Information Table 79. Step One Foods Business Overview Table 80. Step One Foods Cholesterol-Lowering Supplements Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Step One Foods Cholesterol-Lowering Supplements Product Portfolio Table 82. Step One Foods Recent Development Table 83. Solgar Company Information Table 84. Solgar Business Overview Table 85. Solgar Cholesterol-Lowering Supplements Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Solgar Cholesterol-Lowering Supplements Product Portfolio Table 87. Solgar Recent Development Table 88. Pure Encapsulations LLC Company Information Table 89. Pure Encapsulations LLC Business Overview Table 90. Pure Encapsulations LLC Cholesterol-Lowering Supplements Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Pure Encapsulations LLC Cholesterol-Lowering Supplements Product Portfolio Table 92. Pure Encapsulations LLC Recent Development Table 93. ORGANIC INDIA Pvt. Ltd. Company Information Table 94. ORGANIC INDIA Pvt. Ltd. Business Overview Table 95. ORGANIC INDIA Pvt. Ltd. Cholesterol-Lowering Supplements Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. ORGANIC INDIA Pvt. Ltd. Cholesterol-Lowering Supplements Product Portfolio Table 97. ORGANIC INDIA Pvt. Ltd. Recent Development Table 98. Inlife Pharma Private Limite Company Information Table 99. Inlife Pharma Private Limite Business Overview Table 100. Inlife Pharma Private Limite Cholesterol-Lowering Supplements Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Inlife Pharma Private Limite Cholesterol-Lowering Supplements Product Portfolio Table 102. Inlife Pharma Private Limite Recent Development Table 103. Holland & Barrett Company Information Table 104. Holland & Barrett Business Overview Table 105. Holland & Barrett Cholesterol-Lowering Supplements Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Holland & Barrett Cholesterol-Lowering Supplements Product Portfolio Table 107. Holland & Barrett Recent Development Table 108. Himalaya Wellness Company. Company Information Table 109. Himalaya Wellness Company. Business Overview Table 110. Himalaya Wellness Company. Cholesterol-Lowering Supplements Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Himalaya Wellness Company. Cholesterol-Lowering Supplements Product Portfolio Table 112. Himalaya Wellness Company. Recent Development Table 113. HERBAL CREATIONS Company Information Table 114. HERBAL CREATIONS Business Overview Table 115. HERBAL CREATIONS Cholesterol-Lowering Supplements Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. HERBAL CREATIONS Cholesterol-Lowering Supplements Product Portfolio Table 117. HERBAL CREATIONS Recent Development Table 118. Croda International Plc Company Information Table 119. Croda International Plc Business Overview Table 120. Croda International Plc Cholesterol-Lowering Supplements Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Croda International Plc Cholesterol-Lowering Supplements Product Portfolio Table 122. Croda International Plc Recent Development Table 123. Cargill Company Information Table 124. Cargill Business Overview Table 125. Cargill Cholesterol-Lowering Supplements Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Cargill Cholesterol-Lowering Supplements Product Portfolio Table 127. Cargill Recent Development Table 128. Bioglan Company Information Table 129. Bioglan Business Overview Table 130. Bioglan Cholesterol-Lowering Supplements Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Bioglan Cholesterol-Lowering Supplements Product Portfolio Table 132. Bioglan Recent Development Table 133. ADM Company Information Table 134. ADM Business Overview Table 135. ADM Cholesterol-Lowering Supplements Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. ADM Cholesterol-Lowering Supplements Product Portfolio Table 137. ADM Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Cholesterol-Lowering Supplements Distributors List Table 141. Cholesterol-Lowering Supplements Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Cholesterol-Lowering Supplements Product Image Figure 2. Global Cholesterol-Lowering Supplements Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cholesterol-Lowering Supplements Market Size (2021-2032) & (US$ Million) Figure 4. Global Cholesterol-Lowering Supplements Sales (2021-2032) & (Tons) Figure 5. Global Cholesterol-Lowering Supplements Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Cholesterol-Lowering Supplements Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Animal-Based Image Figure 9. Plant-Based Image Figure 10. Others Image Figure 11. Global Cholesterol-Lowering Supplements Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Cholesterol-Lowering Supplements Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Cholesterol-Lowering Supplements Sales Market Share by Type (2021-2032) Figure 14. Global Cholesterol-Lowering Supplements Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 15. Global Cholesterol-Lowering Supplements Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Cholesterol-Lowering Supplements Revenue Market Share by Type (2021-2032) Figure 17. Online Sales Image Figure 18. Offline Sales Image Figure 19. Global Cholesterol-Lowering Supplements Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 20. Global Cholesterol-Lowering Supplements Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Cholesterol-Lowering Supplements Sales Market Share by Application (2021-2032) Figure 22. Global Cholesterol-Lowering Supplements Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 23. Global Cholesterol-Lowering Supplements Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Cholesterol-Lowering Supplements Revenue Market Share by Application (2021-2032) Figure 25. North America Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 26. North America Cholesterol-Lowering Supplements Sales Market Share by Country (2021-2032) Figure 27. U.S. Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 28. Canada Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 29. Mexico Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Europe Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 31. Europe Cholesterol-Lowering Supplements Sales Market Share by Country (2021-2032) Figure 32. Germany Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 33. France Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 34. U.K. Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 35. Italy Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Netherlands Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Asia Pacific Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 38. Asia Pacific Cholesterol-Lowering Supplements Sales Market Share by Country (2021-2032) Figure 39. China Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 40. Japan Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 41. South Korea Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 42. Southeast Asia Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 43. India Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 44. Australia Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 45. South America, Middle East and Africa Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 46. South America, Middle East and Africa Cholesterol-Lowering Supplements Sales Market Share by Country (2021-2032) Figure 47. Brazil Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 48. South Africa Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 49. Saudi Arabia Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Turkey Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 51. Argentina Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 52. UAE Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 53. Egypt Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Chile Cholesterol-Lowering Supplements Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Global Cholesterol-Lowering Supplements Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Cholesterol-Lowering Supplements Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Cholesterol-Lowering Supplements Revenue (2021-2032) & (US$ Million) Figure 58. North America Cholesterol-Lowering Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Cholesterol-Lowering Supplements Revenue (2021-2032) & (US$ Million) Figure 60. Europe Cholesterol-Lowering Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Cholesterol-Lowering Supplements Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Cholesterol-Lowering Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Cholesterol-Lowering Supplements Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Cholesterol-Lowering Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Cholesterol-Lowering Supplements Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Cholesterol-Lowering Supplements Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Animal-Based
  • Plant-Based
  • Others
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Vitabiotics
  • TCI Co. Ltd.
  • Streamline Pharma Pvt. Ltd.
  • Step One Foods
  • Solgar
  • Pure Encapsulations LLC
  • ORGANIC INDIA Pvt. Ltd.
  • Inlife Pharma Private Limite
  • Holland & Barrett
  • Himalaya Wellness Company.
  • HERBAL CREATIONS
  • Croda International Plc
  • Cargill
  • Bioglan
  • ADM

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cholesterol-Lowering Supplements Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cholesterol-Lowering Supplements Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cholesterol-Lowering Supplements Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cholesterol-Lowering Supplements Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cholesterol-Lowering Supplements Market Dynamics
  1. 2.1 Cholesterol-Lowering Supplements Industry Trends
  2. 2.2 Cholesterol-Lowering Supplements Industry Drivers
  3. 2.3 Cholesterol-Lowering Supplements Industry Opportunities and Challenges
  4. 2.4 Cholesterol-Lowering Supplements Industry Restraints
3 Cholesterol-Lowering Supplements Market by Manufacturers
  1. 3.1 Global Cholesterol-Lowering Supplements Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cholesterol-Lowering Supplements Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cholesterol-Lowering Supplements Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cholesterol-Lowering Supplements Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cholesterol-Lowering Supplements Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cholesterol-Lowering Supplements Manufacturers, Product Type & Application
  7. 3.7 Global Cholesterol-Lowering Supplements Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cholesterol-Lowering Supplements Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cholesterol-Lowering Supplements Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cholesterol-Lowering Supplements Tier 1, Tier 2, and Tier 3
4 Cholesterol-Lowering Supplements Market by Type
  1. 4.1 Cholesterol-Lowering Supplements Type Introduction
  2. 4.1.1 Animal-Based
  3. 4.1.2 Plant-Based
  4. 4.1.3 Others
  5. 4.2 Global Cholesterol-Lowering Supplements Sales by Type
  6. 4.2.1 Global Cholesterol-Lowering Supplements Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Cholesterol-Lowering Supplements Sales by Type (2021-2032)
  8. 4.2.3 Global Cholesterol-Lowering Supplements Sales Market Share by Type (2021-2032)
  9. 4.3 Global Cholesterol-Lowering Supplements Revenue by Type
  10. 4.3.1 Global Cholesterol-Lowering Supplements Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Cholesterol-Lowering Supplements Revenue by Type (2021-2032)
  12. 4.3.3 Global Cholesterol-Lowering Supplements Revenue Market Share by Type (2021-2032)
5 Cholesterol-Lowering Supplements Market by Application
  1. 5.1 Cholesterol-Lowering Supplements Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Cholesterol-Lowering Supplements Sales by Application
  5. 5.2.1 Global Cholesterol-Lowering Supplements Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Cholesterol-Lowering Supplements Sales by Application (2021-2032)
  7. 5.2.3 Global Cholesterol-Lowering Supplements Sales Market Share by Application (2021-2032)
  8. 5.3 Global Cholesterol-Lowering Supplements Revenue by Application
  9. 5.3.1 Global Cholesterol-Lowering Supplements Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Cholesterol-Lowering Supplements Revenue by Application (2021-2032)
  11. 5.3.3 Global Cholesterol-Lowering Supplements Revenue Market Share by Application (2021-2032)
6 Global Cholesterol-Lowering Supplements Sales by Region
  1. 6.1 Global Cholesterol-Lowering Supplements Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cholesterol-Lowering Supplements Sales by Region (2021-2032)
  3. 6.2.1 Global Cholesterol-Lowering Supplements Sales by Region (2021-2026)
  4. 6.2.2 Global Cholesterol-Lowering Supplements Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cholesterol-Lowering Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cholesterol-Lowering Supplements Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cholesterol-Lowering Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cholesterol-Lowering Supplements Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cholesterol-Lowering Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cholesterol-Lowering Supplements Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cholesterol-Lowering Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cholesterol-Lowering Supplements Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cholesterol-Lowering Supplements Revenue by Region
  1. 7.1 Global Cholesterol-Lowering Supplements Revenue by Region
  2. 7.1.1 Global Cholesterol-Lowering Supplements Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cholesterol-Lowering Supplements Revenue by Region (2021-2026)
  4. 7.1.3 Global Cholesterol-Lowering Supplements Revenue by Region (2027-2032)
  5. 7.1.4 Global Cholesterol-Lowering Supplements Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cholesterol-Lowering Supplements Revenue (2021-2032)
  8. 7.2.2 North America Cholesterol-Lowering Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cholesterol-Lowering Supplements Revenue (2021-2032)
  11. 7.3.2 Europe Cholesterol-Lowering Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cholesterol-Lowering Supplements Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cholesterol-Lowering Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cholesterol-Lowering Supplements Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cholesterol-Lowering Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Vitabiotics
  2. 8.1.1 Vitabiotics Company Information
  3. 8.1.2 Vitabiotics Business Overview
  4. 8.1.3 Vitabiotics Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Vitabiotics Cholesterol-Lowering Supplements Product Portfolio
  6. 8.1.5 Vitabiotics Recent Developments
  7. 8.2 TCI Co. Ltd.
  8. 8.2.1 TCI Co. Ltd. Company Information
  9. 8.2.2 TCI Co. Ltd. Business Overview
  10. 8.2.3 TCI Co. Ltd. Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 TCI Co. Ltd. Cholesterol-Lowering Supplements Product Portfolio
  12. 8.2.5 TCI Co. Ltd. Recent Developments
  13. 8.3 Streamline Pharma Pvt. Ltd.
  14. 8.3.1 Streamline Pharma Pvt. Ltd. Company Information
  15. 8.3.2 Streamline Pharma Pvt. Ltd. Business Overview
  16. 8.3.3 Streamline Pharma Pvt. Ltd. Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Streamline Pharma Pvt. Ltd. Cholesterol-Lowering Supplements Product Portfolio
  18. 8.3.5 Streamline Pharma Pvt. Ltd. Recent Developments
  19. 8.4 Step One Foods
  20. 8.4.1 Step One Foods Company Information
  21. 8.4.2 Step One Foods Business Overview
  22. 8.4.3 Step One Foods Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Step One Foods Cholesterol-Lowering Supplements Product Portfolio
  24. 8.4.5 Step One Foods Recent Developments
  25. 8.5 Solgar
  26. 8.5.1 Solgar Company Information
  27. 8.5.2 Solgar Business Overview
  28. 8.5.3 Solgar Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Solgar Cholesterol-Lowering Supplements Product Portfolio
  30. 8.5.5 Solgar Recent Developments
  31. 8.6 Pure Encapsulations LLC
  32. 8.6.1 Pure Encapsulations LLC Company Information
  33. 8.6.2 Pure Encapsulations LLC Business Overview
  34. 8.6.3 Pure Encapsulations LLC Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pure Encapsulations LLC Cholesterol-Lowering Supplements Product Portfolio
  36. 8.6.5 Pure Encapsulations LLC Recent Developments
  37. 8.7 ORGANIC INDIA Pvt. Ltd.
  38. 8.7.1 ORGANIC INDIA Pvt. Ltd. Company Information
  39. 8.7.2 ORGANIC INDIA Pvt. Ltd. Business Overview
  40. 8.7.3 ORGANIC INDIA Pvt. Ltd. Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ORGANIC INDIA Pvt. Ltd. Cholesterol-Lowering Supplements Product Portfolio
  42. 8.7.5 ORGANIC INDIA Pvt. Ltd. Recent Developments
  43. 8.8 Inlife Pharma Private Limite
  44. 8.8.1 Inlife Pharma Private Limite Company Information
  45. 8.8.2 Inlife Pharma Private Limite Business Overview
  46. 8.8.3 Inlife Pharma Private Limite Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Inlife Pharma Private Limite Cholesterol-Lowering Supplements Product Portfolio
  48. 8.8.5 Inlife Pharma Private Limite Recent Developments
  49. 8.9 Holland & Barrett
  50. 8.9.1 Holland & Barrett Company Information
  51. 8.9.2 Holland & Barrett Business Overview
  52. 8.9.3 Holland & Barrett Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Holland & Barrett Cholesterol-Lowering Supplements Product Portfolio
  54. 8.9.5 Holland & Barrett Recent Developments
  55. 8.10 Himalaya Wellness Company.
  56. 8.10.1 Himalaya Wellness Company. Company Information
  57. 8.10.2 Himalaya Wellness Company. Business Overview
  58. 8.10.3 Himalaya Wellness Company. Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Himalaya Wellness Company. Cholesterol-Lowering Supplements Product Portfolio
  60. 8.10.5 Himalaya Wellness Company. Recent Developments
  61. 8.11 HERBAL CREATIONS
  62. 8.11.1 HERBAL CREATIONS Company Information
  63. 8.11.2 HERBAL CREATIONS Business Overview
  64. 8.11.3 HERBAL CREATIONS Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 HERBAL CREATIONS Cholesterol-Lowering Supplements Product Portfolio
  66. 8.11.5 HERBAL CREATIONS Recent Developments
  67. 8.12 Croda International Plc
  68. 8.12.1 Croda International Plc Company Information
  69. 8.12.2 Croda International Plc Business Overview
  70. 8.12.3 Croda International Plc Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Croda International Plc Cholesterol-Lowering Supplements Product Portfolio
  72. 8.12.5 Croda International Plc Recent Developments
  73. 8.13 Cargill
  74. 8.13.1 Cargill Company Information
  75. 8.13.2 Cargill Business Overview
  76. 8.13.3 Cargill Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cargill Cholesterol-Lowering Supplements Product Portfolio
  78. 8.13.5 Cargill Recent Developments
  79. 8.14 Bioglan
  80. 8.14.1 Bioglan Company Information
  81. 8.14.2 Bioglan Business Overview
  82. 8.14.3 Bioglan Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bioglan Cholesterol-Lowering Supplements Product Portfolio
  84. 8.14.5 Bioglan Recent Developments
  85. 8.15 ADM
  86. 8.15.1 ADM Company Information
  87. 8.15.2 ADM Business Overview
  88. 8.15.3 ADM Cholesterol-Lowering Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 ADM Cholesterol-Lowering Supplements Product Portfolio
  90. 8.15.5 ADM Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cholesterol-Lowering Supplements Value Chain Analysis
  2. 9.1.1 Cholesterol-Lowering Supplements Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cholesterol-Lowering Supplements Production Mode & Process
  6. 9.2 Cholesterol-Lowering Supplements Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cholesterol-Lowering Supplements Distributors
  9. 9.2.3 Cholesterol-Lowering Supplements Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research